JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Heeren, P. A.M.
Right arrow Articles by Plukker, J. Th.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Heeren, P. A.M.
Right arrow Articles by Plukker, J. Th.M.
Journal of Nuclear Medicine Vol. 45 No. 6 980-987
© 2004 by Society of Nuclear Medicine


Clinical Investigations

Detection of Distant Metastases in Esophageal Cancer with 18F-FDG PET

Pierre A.M. Heeren, MD1, Pieter L. Jager, MD, PhD2, Fons Bongaerts, MD3, Hendrik van Dullemen, MD, PhD4, Wim Sluiter, MD, PhD5 and John Th.M. Plukker, MD, PhD1

1 Department of Surgical Oncology, University Hospital of Groningen, Groningen, The Netherlands
2 Department of Nuclear Medicine/PET Center, University Hospital of Groningen, Groningen, The Netherlands
3 Department of Radiology, University Hospital of Groningen, Groningen, The Netherlands
4 Department of Gastroenterology, University Hospital of Groningen, Groningen, The Netherlands
5 Department of Medical Statistics, University Hospital of Groningen, Groningen, The Netherlands

Standard staging of esophageal and gastroesophageal junction (GEJ) tumors substantially lacks accuracy. The aim of this study was to investigate whether the addition of PET with 18F-FDG is a valuable gain in the initial staging. Methods: Between January 1996 and January 2002, 18F-FDG PET was performed in 74 patients. Conventional staging included CT in all patients and well-performed endoscopic ultrasonography (EUS) in 52 patients. They were compared with 18F-FDG PET with pathology and follow-up of suspicious lesions as the gold standard. Results: PET identified 70 primary tumors (sensitivity, 95%). Sensitivity to identify locoregional metastases was highest for EUS (69%) but was not different for CT and PET (44% and 55%, respectively). PET was able to identify distant nodal disease in 71% (17/24 patients) compared with 29% (7/24 patients) after combined CT/EUS alone (P = 0.021). Sensitivity to detect distant nodal and systemic (M1) disease increased with PET (78% vs. 37%; P = 0.012). PET upstaged 15 patients (15/74; 20%) correctly as M1 disease, missed by CT/EUS, and correctly downstaged 4 patients (5%) from M1 to M0 disease. However, false upstaging and downstaging was encountered in 5 (7%) and 3 (4%) patients, respectively. Conclusion: PET improves the currently applied staging of esophageal and GEJ tumors, particularly by ameliorating the detection of M1 disease.

Key Words: esophageal cancer • 18F-FDG PET • upstaging




This article has been cited by other articles:


Home page
Eur. J. Cardiothorac. Surg.Home page
R. G. Berrisford, W.-L. Wong, D. Day, E. Toy, M. Napier, K. Mitchell, and S. Wajed
The decision to operate: role of integrated computed tomography positron emission tomography in staging oesophageal and oesophagogastric junction cancer by the multidisciplinary team
Eur. J. Cardiothorac. Surg., June 1, 2008; 33(6): 1112 - 1116.
[Abstract] [Full Text] [PDF]


Home page
RadioGraphicsHome page
J. F. Bruzzi, R. F. Munden, M. T. Truong, E. M. Marom, B. S. Sabloff, G. W. Gladish, R. B. Iyer, T.-S. Pan, H. A. Macapinlac, and J. J. Erasmus
PET/CT of Esophageal Cancer: Its Role in Clinical Management
RadioGraphics, November 1, 2007; 27(6): 1635 - 1652.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. Guo, H. Zhu, Y. Xi, B. Zhang, L. Li, Y. Huang, J. Zhang, Z. Fu, G. Yang, S. Yuan, et al.
Diagnostic and Prognostic Value of 18F-FDG PET/CT for Patients with Suspected Recurrence from Squamous Cell Carcinoma of the Esophagus
J. Nucl. Med., August 1, 2007; 48(8): 1251 - 1258.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Rizk, R. J. Downey, T. Akhurst, M. Gonen, M. S. Bains, S. Larson, and V. Rusch
Preoperative (18)[F]-Fluorodeoxyglucose Positron Emission Tomography Standardized Uptake Values Predict Survival After Esophageal Adenocarcinoma Resection.
Ann. Thorac. Surg., March 1, 2006; 81(3): 1076 - 1081.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
R. J. Cerfolio, A. S. Bryant, B. Ohja, A. A. Bartolucci, and M. A. Eloubeidi
The accuracy of endoscopic ultrasonography with fine-needle aspiration, integrated positron emission tomography with computed tomography, and computed tomography in restaging patients with esophageal cancer after neoadjuvant chemoradiotherapy
J. Thorac. Cardiovasc. Surg., June 1, 2005; 129(6): 1232 - 1241.
[Abstract] [Full Text] [PDF]


Home page
JNMHome page
H. L. van Westreenen, D. C.P. Cobben, P. L. Jager, H. M. van Dullemen, J. Wesseling, P. H. Elsinga, and J. Th. Plukker
Comparison of 18F-FLT PET and 18F-FDG PET in Esophageal Cancer
J. Nucl. Med., March 1, 2005; 46(3): 400 - 404.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 2004 by the Society of Nuclear Medicine.